Breaking News Instant updates and real-time market news.

ACRS

Aclaris Therapeutics

$16.86

-0.27 (-1.58%)

12:25
08/14/18
08/14
12:25
08/14/18
12:25

Cantor consumer products analysts to hold analyst/industry conference call

Analysts, along with Dr. Julian Mackay-Wigtgan, MD, from Columbia University and Dr. Luis Garza, from John Hopkins, discuss the best JAK (Janus kinase) inhibitors for treating hair loss on an Analyst/Industry conference call to be held on August 14 at 1 pm.

  • 14

    Aug

ACRS Aclaris Therapeutics
$16.86

-0.27 (-1.58%)

07/17/18
CANT
07/17/18
NO CHANGE
CANT
Overweight
Aclaris offers best risk/reward of hair loss players, says Cantor Fitzgerald
The potential for JAK inhibitors to treat alopecia areata may be underappreciated by investors because the Street does not appear to be ascribing enough value to the opportunity, Cantor Fitzgerald analyst Louise Chen tells investors in a research note. Of the three companies she covers developing JAKs for hair loss, Aclaris Therapeutics (ACRS), Eli Lilly (LLY) and Pfizer (PFE), the analyst believes Aclaris offers the best risk/reward and greatest upside potential. The company has a market cap below $700M and two potential "shots on goal" for alopecia areata, Chen writes. She estimates combined peak sales of $1B-plus for both opportunities and keeps an Overweight rating on Aclaris. The physicians the analyst spoke to believe the company's JAKs for hair loss will work.
04/10/18
CANT
04/10/18
NO CHANGE
Target $50
CANT
Overweight
Aclaris insider buying underscores attractive valuation, says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen highlights "meaningful" recent insider buying from executive officers at Aclaris Therapeutics, including, CEO Neal Walker, CFO Frank Ruffo and Chairman Stephen Tullman. Chen believes the stock purchases underscore her view that Aclaris shares are undervalued. The market underappreciates the commercial opportunity for Eskata, A-101 for warts, JAK for hair loss as well as vitiligo and the Confluence assets, Chen tells investors in a research note. She keeps an Overweight rating on Aclaris Therapeutics with a $50 price target.
03/28/18
LEER
03/28/18
INITIATION
Target $52
LEER
Outperform
Aclaris Therapeutics assumed with an Outperform at Leerink
Leerink analyst Etzer Darout assumed coverage of Aclaris Therapeutics with an Outperform rating and $52 price target. The company's lead program Eskata offers a new treatment option for patients with seborrheic keratosis with reduced risk of dyspigmentation and scarring, the analyst tells investors in a research note.
02/08/18
GUGG
02/08/18
INITIATION
Target $53
GUGG
Buy
Aclaris Therapeutics initiated with a Buy at Guggenheim
Guggenheim initiated Aclaris Therapeutics with a Buy and $53 price target.

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
12/13/18
12/13
15:16
12/13/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$66.80

0.7 (1.06%)

15:11
12/13/18
12/13
15:11
12/13/18
15:11
Hot Stocks
Starbucks says starting new rewards program in China »

Starbucks executives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

FFIN

First Financial

$60.53

-0.8 (-1.30%)

15:08
12/13/18
12/13
15:08
12/13/18
15:08
Hot Stocks
First Financial elects John Ruzicka Chief Information Officer »

First Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

RDNT

RadNet

$12.61

0.05 (0.40%)

15:08
12/13/18
12/13
15:08
12/13/18
15:08
Hot Stocks
RadNet and MemorialCare expand joint venture »

MemorialCare and RadNet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:05
12/13/18
12/13
15:05
12/13/18
15:05
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

SFLY

Shutterfly

$43.18

-1.65 (-3.68%)

15:04
12/13/18
12/13
15:04
12/13/18
15:04
Recommendations
Shutterfly analyst commentary  »

Shutterfly weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$35.90

5.835 (19.41%)

15:04
12/13/18
12/13
15:04
12/13/18
15:04
Recommendations
Health Insurance Innovations analyst commentary  »

Settlement should remove…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

COST

Costco

$225.93

-1.89 (-0.83%)

15:04
12/13/18
12/13
15:04
12/13/18
15:04
Options
Costco options imply 5.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HIIQ

Health Insurance Innovations

$35.90

5.835 (19.41%)

15:02
12/13/18
12/13
15:02
12/13/18
15:02
Recommendations
Health Insurance Innovations analyst commentary  »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MRVL

Marvell

$15.53

0.18 (1.17%)

15:00
12/13/18
12/13
15:00
12/13/18
15:00
Options
Size time spread in Marvell Tech following an analyst upgrade »

Size time spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

  • 08

    Jan

G

Genpact

$28.14

-0.27 (-0.95%)

, EXLS

ExlService

$55.76

0.13 (0.23%)

14:57
12/13/18
12/13
14:57
12/13/18
14:57
Conference/Events
William Blair IT/BPO services analysts to hold analyst/industry conference call »

India IT/BPO Services…

G

Genpact

$28.14

-0.27 (-0.95%)

EXLS

ExlService

$55.76

0.13 (0.23%)

WNS

WNS Holdings

$46.99

-0.82 (-1.72%)

GLOB

Globant

$55.66

-1.37 (-2.40%)

PRFT

Perficient

$23.49

-0.28 (-1.18%)

VRTU

Virtusa

$41.05

1.2 (3.01%)

INFY

Infosys

$9.85

0.19 (1.97%)

WIT

Wipro

$5.30

0.19 (3.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$66.61

0.51 (0.77%)

14:56
12/13/18
12/13
14:56
12/13/18
14:56
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks says 80% of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

AAPL

Apple

$170.45

1.36 (0.80%)

, INTC

Intel

$48.11

0.28 (0.59%)

14:55
12/13/18
12/13
14:55
12/13/18
14:55
Recommendations
Apple, Intel analyst commentary  »

Lynx questions…

AAPL

Apple

$170.45

1.36 (0.80%)

INTC

Intel

$48.11

0.28 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

SBUX

Starbucks

$66.48

0.38 (0.57%)

14:50
12/13/18
12/13
14:50
12/13/18
14:50
Options
Heavy trading in Starbucks Weekly options during the company's Investor Day »

Heavy trading in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

ADBE

Adobe

$247.50

2.06 (0.84%)

14:49
12/13/18
12/13
14:49
12/13/18
14:49
Options
Adobe options imply 7.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CMG

Chipotle

$472.11

0.91 (0.19%)

, DANOY

Danone

$0.00

(0.00%)

14:44
12/13/18
12/13
14:44
12/13/18
14:44
Hot Stocks
Chipotle announces hiring of Chief Legal Officer and Chief Development Officer »

Chipotle Mexican Grill…

CMG

Chipotle

$472.11

0.91 (0.19%)

DANOY

Danone

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 06

    Feb

SBUX

Starbucks

$66.51

0.41 (0.62%)

14:41
12/13/18
12/13
14:41
12/13/18
14:41
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks says goal to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

GPX

GP Strategies

$13.13

0.06 (0.46%)

14:41
12/13/18
12/13
14:41
12/13/18
14:41
Conference/Events
GP Strategies management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Dec

TSLA

Tesla

$371.33

4.57 (1.25%)

, GOOG

Alphabet

$1,057.32

-6.24 (-0.59%)

14:41
12/13/18
12/13
14:41
12/13/18
14:41
Periodicals
Tesla's Vaish resigns to start company at Google's Area120, CNBC says »

Parag Vaish, head of…

TSLA

Tesla

$371.33

4.57 (1.25%)

GOOG

Alphabet

$1,057.32

-6.24 (-0.59%)

GOOGL

Alphabet Class A

$1,068.33

-5.33 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 03

    Mar

GPX

GP Strategies

$13.13

0.06 (0.46%)

14:40
12/13/18
12/13
14:40
12/13/18
14:40
Conference/Events
GP Strategies management to meet with Barrington »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Dec

HIIQ

Health Insurance Innovations

$36.84

6.775 (22.53%)

14:40
12/13/18
12/13
14:40
12/13/18
14:40
Recommendations
Health Insurance Innovations analyst commentary  »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SPY

SPDR S&P 500 ETF Trust

$264.50

-1.03 (-0.39%)

, SPX

S&P 500

$0.00

(0.00%)

14:36
12/13/18
12/13
14:36
12/13/18
14:36
General news
NYPD says monitoring multiple bomb threats, not considered credible »

The official Twitter of…

SPY

SPDR S&P 500 ETF Trust

$264.50

-1.03 (-0.39%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
12/13/18
12/13
14:35
12/13/18
14:35
General news
Saudi PIF has been a swing buyer of stocks »

Saudi PIF has been a…

SBUX

Starbucks

$66.43

0.33 (0.50%)

14:32
12/13/18
12/13
14:32
12/13/18
14:32
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks to expand nitro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

SBUX

Starbucks

$66.41

0.31 (0.47%)

14:31
12/13/18
12/13
14:31
12/13/18
14:31
Hot Stocks
Starbucks bringing delivery to 25% of company-owned U.S. stores by Q2 2019 »

Starbucks is expanding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.